What question did this study set out to answer?

This study aims to explore the relationship between anti-Toxoplasma IgG antibodies and BPD symptom severity in females diagnosed with the disorder.

April 4, 2026Neuropsychiatric Disease and Treatment0 citationsOpen Access

Correlates of Anti-Toxoplasma IgG Antibodies in Females with Borderline Personality Disorder: A Pilot Cross-Sectional Study

MOMarie OciskovaUniversity Hospital Olomouc JPJán PraškoConstantine the Philosopher University in Nitra KBKamila BělohradováUniversity Hospital Olomouc

Key Points

This study aims to explore the relationship between anti-Toxoplasma IgG antibodies and BPD symptom severity in females diagnosed with the disorder.
Sample of 77 female patients diagnosed with BPD under inpatient care.
Measured T. gondii antibodies (IgG, IgA, IgM) using ELISA.
Conducted psychiatric assessments including various standardized questionnaires.
Data analyzed using descriptive statistics and several statistical tests, including Fisher’s exact test and t-tests.
11.7% of patients were seropositive for T. gondii IgG antibodies.
Seropositive group reported more suicidal ideations (effect size d = 0.67).
Less severe symptoms of abandonment (d = 0.67) and depression (d = 0.57) noted in seropositive group.
Other symptoms showed small to marginal differences between groups.

Abstract

Background: Latent Toxoplasma gondii infection has been associated with various mental health conditions, but its potential role in the pathophysiology of borderline personality disorder (BPD) remains unclear. This pilot study investigated associations of anti- Toxoplasma IgG seropositivity with the severity of BPD symptoms among adult females with BPD. Methods: The sample consisted of 77 female patients diagnosed with BPD who were admitted for psychotherapeutic inpatient care for the personality disorder. T. gondii antibodies (IgG, IgA, and IgM) were measured using ELISA. Psychiatric and psychological assessments included Clinical Global Impression for BPD, Borderline Evaluation of Severity over Time, Buss-Perry Aggression Questionnaire, Suicide Behaviors Questionnaire-Revised, Beck Anxiety Inventory, and Beck Depression Inventory-II. Data were analyzed using descriptive statistics, Fisher’s exact test, χ 2 test, t -tests, and Mann–Whitney U -tests. Results: Only nine patients (11.7%) were seropositive for T. gondii IgG antibodies. Although none of the hypothesized differences reached statistical significance, several medium-sized effects indicated potentially clinically relevant differences between the seropositive and seronegative groups. Specifically, the seropositive group reported more suicidal ideations during the past year (d = 0.67) and exhibited less severe symptoms of abandonment (d = 0.67) and depression (d = 0.57). The remaining symptoms showed small (suicidality, aggression, anger, and anxiety) or marginal (overall BPD severity, impulsivity) differences between the two groups. Conclusion: This exploratory pilot study observed lower anti- Toxoplasma IgG seropositivity among patients with BPD than previously expected. Although the findings were not statistically significant, several trends indicated that seropositive patients might differ from the seronegative group. These preliminary results should be viewed as hypothesis-generating and validated in larger samples. Keywords: Toxoplasma gondii , latent toxoplasmosis, borderline personality disorder, aggression, suicidality

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper